CLINICAL_TRIALS ClinicalTrials.gov record update

Preemptive Infusion of Donor Lymphocytes Depleted of TCR (Alpha-beta) + T Cells and CD19+ B Cells Following Allogeneic Stem Cell Transplantation

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03939585
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-25T22:27:04.776637+00:00
Published At: 2024-12-05T00:00:00+00:00
Record Updated At: 2024-12-05
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Allogeneic Stem Cell Transplant Candidate", "Acute Myeloid/Lymphoblastic Leukemia", "Myelodysplastic Syndrome", "Myeloproliferative Neoplasm", "Lymphoproliferative Disorders"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2024-12-05"
protocolSection.identificationModule.nctId: "NCT03939585"
protocolSection.identificationModule.officialTitle: "Preemptive Infusion of Donor Lymphocytes Depleted of TCR (Alpha-beta) + T Cells and CD19+ B Cells Following Allogeneic Stem Cell Transplantation"
protocolSection.statusModule.overallStatus: "WITHDRAWN"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.